PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24060614-9	2013	On the other hand, quercitrin and taxifolin decreased Rankl gene expression in osteoblasts, suggesting an inhibition of osteoclast formation.	quercitrin	19-29	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	54-59	
30366383-6	2018	Moreover, quercitrin implant surfaces significantly decreased the expression of osteoclast related genes in vitro (Trap, CalcR, Ctsk, H+ATPase, Mmp9) and in vivo (Ctsk, H+ATPase, Mmp9) as well as the expression of RankL in vivo.	quercitrin	10-20	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	214-219	
20822887-7	2012	Pretreatment with quercitrin also reduced the increase in bone-resorbing factor, receptor activator of nuclear factor-kB ligand (RANKL) and oxidative damage markers (malondialdehyde, protein carbonyl, and nitrotyrosine) induced by H(2)O(2).	quercitrin	18-28	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	81-127	
20822887-7	2012	Pretreatment with quercitrin also reduced the increase in bone-resorbing factor, receptor activator of nuclear factor-kB ligand (RANKL) and oxidative damage markers (malondialdehyde, protein carbonyl, and nitrotyrosine) induced by H(2)O(2).	quercitrin	18-28	tumor necrosis factor (ligand) superfamily, member 11	Mus musculus	129-134